According to ImmunoGen 's latest financial reports the company's current earnings are A$0.28 Billion. In 2022 the company made an earning of -A$0.35 Billion a decrease over its 2021 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.